SCHEMBL114932

SCHEMBL114932

COc1ncc(-c2ccccc2N2CCN(C(C=O)n3ccc4cc(F)cnc43)CC2)cn1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.35
CYP1A2 P05177 5/20 0.35
HSD17B10 Q99714 4/20 0.35
CASP1 P29466 3/20 0.35
CASP7 P55210 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
USP2 O75604 1/20 0.35
ALDH1A1 P00352 4/20 0.33
TSHR P16473 3/20 0.33
MAPK1 P28482 3/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2C9 P11712 2/20 0.33
FEN1 P39748 2/20 0.33
ALOX5AP P20292 1/20 0.33
HTR1A P08908 5/20 0.33
HTR7 P34969 4/20 0.33
DRD3 P35462 2/20 0.33
DRD2 P14416 1/20 0.33
DRD1 P21728 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL113317 0.91 DHFR (0.35) DHFRCYP1A2HSD17B10ALDH1A1MAPK1
SCHEMBL113266 0.87 DHFR (0.35) DHFRCYP1A2HSD17B10MEN1KMT2A
SCHEMBL113412 0.81 DHFR (0.35) DHFRHTR1AHTR7KCNH2
SCHEMBL115607 0.81 HTR1A (0.37) DHFRMEN1KMT2AALDH1A1MAPK1
SCHEMBL114669 0.80 MAPT (0.34) DHFRHTR1AHTR7SLC2A1SLC2A3
SCHEMBL115724 0.80 DHFR (0.33) DHFRHTR1AHTR7KCNH2
SCHEMBL114773 0.78 OGA (0.34) DHFRMEN1KMT2ATSHRCYP3A4
SCHEMBL116207 0.78 DHFR (0.33) DHFRCYP1A2HSD17B10ALDH1A1MAPK1
SCHEMBL115569 0.77 HTR1A (0.38) HTR1AHTR7KCNH2
SCHEMBL116262 0.77 CXCR3 (0.35) DHFRCYP1A2HSD17B10ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424840-A1 CXCR3 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-03-07 EP disclosed
WO-2010126811-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO disclosed